SecBot SecBot
8-K ·Filed Aug 19, 2026

ASBP

Aspire Biopharma Holdings, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001493152-26-039135
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

This is a routine investor presentation distribution with no new financial information. Monitor for any subsequent filings that may contain material updates from the presentation content.

DirectionNeutral
Confidencelow
Horizonimmediate
Latest settled — T+20d
ASBP ▲ +15.44% at T+20d
NEUTRAL call +15.44% · α vs SPY +17.39% · entry $7.90 → $9.12
Next anchor: T+60d in 15d
Latest observation: T+46 +3.21% FF3 residual α
Entry = T+0 close
Aug 19, 2026
via day close
T+1d
-1.01%
call -1.01% · α -0.17%
$7.82
settled 2mo ago
T+5d
+5.44%
call +5.44% · α +5.83%
$8.33
settled 2mo ago
T+20d
+15.44%
call +15.44% · α +17.39%
$9.12
settled 6w ago
T+60d
Pending
in 15d

Price Chart

Loading chart...

Executive Summary

Aspire Biopharma Holdings, Inc. filed an 8-K on August 19, 2026, solely to announce the distribution of an investor presentation (Exhibit 99.1). The filing contains no financial data, guidance, or material corporate events—it is a routine Regulation FD disclosure. The investor presentation itself was provided as a series of image files with no extractable text content, making the substance of the presentation unavailable for analysis.

Key Facts

  • Filed 8-K on August 19, 2026 for Regulation FD disclosure
  • Company intends to distribute an investor presentation (Exhibit 99.1)
  • No financial data, guidance, or material events disclosed in the filing text
  • Investor presentation content is embedded as image files with no extractable text

Financial Impact

No financial data disclosed in the filing

Risk Factors

  • No material information disclosed; stock may trade on presentation content not captured in this filing
  • Low market cap ($11M) micro-cap stock with limited institutional ownership

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-039135
Document: 0001493152-26-039135-index-headers.html0001493152-26-039135
Document: 0001493152-26-039135-index.html0001493152-26-039135
Document: 0001493152-26-039135.txt0001493152-26-039135
5 reports for ASBP
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ASBP — sortable, filterable
TypeNow
Oct 20, 2026
7d ago
8-K/A
MIXED ★ 7/10
$8.85awaiting T+20—$8.44 (−4.63%)
Aug 19, 2026
9w ago
8-K
NEUTRAL ★ 2/10
$7.90 $9.12▲ +15.44%▲ +17.39%$8.44 (+6.84%)
Aug 10, 2026
11w ago
8-K
BULLISH ★ 7/10
$7.79 $8.85▲ +13.61%▲ +14.52%$8.44 (+8.34%)
Jul 20, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$7.54 $7.64▲ +1.33%▼ −1.24%$8.44 (+11.94%)
Jun 12, 2026
19w ago
8-K
BULLISH ★ 8/10
$4.96 $6.01▲ +21.17%▲ +19.39%$8.44 (+70.16%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 6h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 19, 2026